University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
About University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
The Medical University of Gdańsk is the largest medical academic institution in northern Poland. It educates more than 5000 undergraduate and postgraduate students in four faculties.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eisai Inc.
2
Debiopharm International SA
1
Oncopeptides AB
1
Clinical Trials at University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
During the past decade, University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
1995-06-01
2006-12-01
Completed
195
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
1995-09-01
2006-12-01
Completed
86
Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL
2016-06-15
2021-06-25
Completed
100
Study of Melphalan Flufenamide (Melflufen) in Combination With Daratumumab in Relapsed Refractory Multiple Myeloma
2020-12-07
2022-02-07
Terminated
54
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
According to Clinical.Site data, the most researched conditions in "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology" are
"Lymphoma, T-Cell, Cutaneous" (2 trials), "Mycosis Fungoides" (2 trials), "Sezary Syndrome" (2 trials), "B-cell Non-Hodgkin's Lymphoma" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology" in a lesser frequency.
Clinical Trials Intervention Types at University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
Most popular intervention types in "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ONTAK" (2 trials), "Daratumumab" (1 trials), "Debio 1562" (1 trials), "Dexamethasone" (1 trials) and "Melphalan Flufenamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
The vast majority of trials in "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology" are
4 trials for "All" genders.
Clinical Trials Status at University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology
Currently, there are NaN active trials in "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".